These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7674685)

  • 41. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary management of angina: part II. Medical management of chronic stable angina.
    Zanger DR; Solomon AJ; Gersh BJ
    Am Fam Physician; 2000 Jan; 61(1):129-38. PubMed ID: 10643954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mono- or combination therapy with myocardial and coronary active drugs in ischemic heart disease].
    Urbaszek W
    Z Gesamte Inn Med; 1985 Sep; 40(17):517-22. PubMed ID: 2867652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
    Jackson G
    Int J Clin Pract; 2001 May; 55(4):256-61. PubMed ID: 11406911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable angina as a manifestation of ischemic heart disease: medical management.
    Roberts R
    Circulation; 1985 Dec; 72(6 Pt 2):V145-54. PubMed ID: 2866048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
    Hanai Y; Mita M; Hishinuma S; Shoji M
    Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ischemic myocardial metabolism and antianginal drugs].
    Ichihara K
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):403-12. PubMed ID: 3549484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease.
    O'Rourke RA
    Am J Cardiol; 1985 Dec; 56(16):34H-40H. PubMed ID: 2866705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug therapy in angina pectoris].
    Follath F
    Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
    Shangina OA; Kostin VI; Koturga LI
    Klin Med (Mosk); 2005; 83(7):34-7. PubMed ID: 16117422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of various combination therapies in patients with coronary heart disease].
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
    Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia.
    Crawford MH
    Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antianginal drug therapy for silent myocardial ischemia.
    Frishman WH; Teicher M
    Am Heart J; 1987 Jul; 114(1 Pt 1):140-7. PubMed ID: 2886034
    [No Abstract]   [Full Text] [Related]  

  • 60. [Risk management of coronary artery disease--pharmacological therapy].
    Hofmann T
    Wien Med Wochenschr; 2004 Jun; 154(11-12):266-81. PubMed ID: 15287703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.